Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine + 5-FU/LV in Advanced Colorectal Cancer
NCT00003001Phase 2Unknown
- Sponsor
- Stony Brook University
- Start
- Apr 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of gemcitabine in colorectal cancer (CRC), sponsored by Stony Brook University. Primary endpoints: Response Rate and Toxic Effect Profile. Status: unknown.
02
Drugs
gemcitabine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00003001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003001.